Repligen
(NASDAQ:RGEN)
$148.49
-3.57[-2.35%]
Last update: 3:22PM Get Real Time Here
37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
2
Feb
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RGEN
MEDP

FAQ

Q

How do I buy Repligen (RGEN) stock?

A

You can purchase shares of Repligen (NASDAQ: RGEN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Repligen's (RGEN) competitors?

Q

What is the target price for Repligen (RGEN) stock?

A

The latest price target for Repligen (NASDAQ: RGEN) was reported by JP Morgan on Thursday, May 2, 2024. The analyst firm set a price target for 200.00 expecting RGEN to rise to within 12 months (a possible 34.69% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Repligen (RGEN)?

A

The stock price for Repligen (NASDAQ: RGEN) is $148.49 last updated Today at May 30, 2024 at 3:22 PM EDT.

Q

Does Repligen (RGEN) pay a dividend?

A

There are no upcoming dividends for Repligen.

Q

When is Repligen (NASDAQ:RGEN) reporting earnings?

A

Repligen’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Q

Is Repligen (RGEN) going to split?

A

There is no upcoming split for Repligen.

Q

What sector and industry does Repligen (RGEN) operate in?

A

Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch